
Jia-hai Lee
Examiner (ID: 19110, Phone: (571)270-1691 , Office: P/1676 )
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1658, 1676 |
| Total Applications | 595 |
| Issued Applications | 247 |
| Pending Applications | 119 |
| Abandoned Applications | 240 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13899111
[patent_doc_number] => 20190038760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-07
[patent_title] => CO-ADMINISTRATION OF AN AGENT LINKED TO AN INTERNALIZATION PEPTIDE WITH AN ANTI-INFLAMMATORY
[patent_app_type] => utility
[patent_app_number] => 16/034235
[patent_app_country] => US
[patent_app_date] => 2018-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23709
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16034235
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/034235 | CO-ADMINISTRATION OF AN AGENT LINKED TO AN INTERNALIZATION PEPTIDE WITH AN ANTI-INFLAMMATORY | Jul 11, 2018 | Abandoned |
Array
(
[id] => 13576923
[patent_doc_number] => 20180340010
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-29
[patent_title] => METHOD FOR PRODUCING A COMPOSITION FOR TREATING A TOOTH LESION
[patent_app_type] => utility
[patent_app_number] => 16/025344
[patent_app_country] => US
[patent_app_date] => 2018-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9126
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16025344
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/025344 | Method for producing a composition for treating a tooth lesion | Jul 1, 2018 | Issued |
Array
(
[id] => 13618729
[patent_doc_number] => 20180360916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => Isolation and Identification of Glycosaminoglycans
[patent_app_type] => utility
[patent_app_number] => 16/020463
[patent_app_country] => US
[patent_app_date] => 2018-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22382
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16020463
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/020463 | Isolation and Identification of Glycosaminoglycans | Jun 26, 2018 | Abandoned |
Array
(
[id] => 13840499
[patent_doc_number] => 20190023734
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-24
[patent_title] => SELECTIVE PHOTOACTIVATION OF AMINO ACIDS FOR SINGLE STEP PEPTIDE COUPLING
[patent_app_type] => utility
[patent_app_number] => 16/019449
[patent_app_country] => US
[patent_app_date] => 2018-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16787
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16019449
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/019449 | Selective photoactivation of amino acids for single step peptide coupling | Jun 25, 2018 | Issued |
Array
(
[id] => 14182847
[patent_doc_number] => 20190111128
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-18
[patent_title] => STABILISATION OF POLYPEPTIDES
[patent_app_type] => utility
[patent_app_number] => 16/013117
[patent_app_country] => US
[patent_app_date] => 2018-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30043
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16013117
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/013117 | STABILISATION OF POLYPEPTIDES | Jun 19, 2018 | Abandoned |
Array
(
[id] => 13563897
[patent_doc_number] => 20180333496
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-22
[patent_title] => PEPTIDE-MEDIATED INTRAVESICAL DELIVERY OF THERAPEUTIC AND DIAGNOSTIC AGENTS
[patent_app_type] => utility
[patent_app_number] => 16/011378
[patent_app_country] => US
[patent_app_date] => 2018-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7449
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16011378
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/011378 | PEPTIDE-MEDIATED INTRAVESICAL DELIVERY OF THERAPEUTIC AND DIAGNOSTIC AGENTS | Jun 17, 2018 | Abandoned |
Array
(
[id] => 13492371
[patent_doc_number] => 20180297728
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => FAST DISSOLVING PHARMACEUTICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/010412
[patent_app_country] => US
[patent_app_date] => 2018-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10427
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16010412
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/010412 | FAST DISSOLVING PHARMACEUTICAL COMPOSITION | Jun 15, 2018 | Abandoned |
Array
(
[id] => 14273737
[patent_doc_number] => 20190134153
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => IMMUNOMODULATORY EFFECT OF INHALED KINASE INHIBITOR PEPTIDES IN LUNG
[patent_app_type] => utility
[patent_app_number] => 16/005408
[patent_app_country] => US
[patent_app_date] => 2018-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61950
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16005408
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/005408 | IMMUNOMODULATORY EFFECT OF INHALED KINASE INHIBITOR PEPTIDES IN LUNG | Jun 10, 2018 | Abandoned |
Array
(
[id] => 19013024
[patent_doc_number] => 11919939
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-05
[patent_title] => Beta-2-glycoprotein 1 derived peptide and use thereof for treating antiphospholipid syndrome
[patent_app_type] => utility
[patent_app_number] => 16/615460
[patent_app_country] => US
[patent_app_date] => 2018-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 13
[patent_no_of_words] => 12395
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16615460
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/615460 | Beta-2-glycoprotein 1 derived peptide and use thereof for treating antiphospholipid syndrome | May 22, 2018 | Issued |
Array
(
[id] => 13551813
[patent_doc_number] => 20180327454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-15
[patent_title] => PEPTIDE PHARMACEUTICALS
[patent_app_type] => utility
[patent_app_number] => 15/986707
[patent_app_country] => US
[patent_app_date] => 2018-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61210
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15986707
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/986707 | PEPTIDE PHARMACEUTICALS | May 21, 2018 | Abandoned |
Array
(
[id] => 13733107
[patent_doc_number] => 20180371021
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/975298
[patent_app_country] => US
[patent_app_date] => 2018-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 89599
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15975298
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/975298 | PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF | May 8, 2018 | Abandoned |
Array
(
[id] => 15828705
[patent_doc_number] => 20200129634
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => ANTIMICROBIAL PEPTIDES AND METHODS OF TREATING GRAM-NEGATIVE PATHOGENS: POLAR AND NON-POLAR FACE ANALOGS
[patent_app_type] => utility
[patent_app_number] => 16/606454
[patent_app_country] => US
[patent_app_date] => 2018-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21996
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16606454
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/606454 | Antimicrobial peptides and methods of treating gram-negative pathogens: polar and non-polar face analogs | Apr 18, 2018 | Issued |
Array
(
[id] => 14243895
[patent_doc_number] => 10272130
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2019-04-30
[patent_title] => Oral anaerobic glutathione supplement in liposome suspension
[patent_app_type] => utility
[patent_app_number] => 15/955608
[patent_app_country] => US
[patent_app_date] => 2018-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 13
[patent_no_of_words] => 9255
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15955608
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/955608 | Oral anaerobic glutathione supplement in liposome suspension | Apr 16, 2018 | Issued |
Array
(
[id] => 13440805
[patent_doc_number] => 20180271945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => UROCORTIN 2 ANALOGS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/953102
[patent_app_country] => US
[patent_app_date] => 2018-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11887
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15953102
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/953102 | UROCORTIN 2 ANALOGS AND USES THEREOF | Apr 12, 2018 | Abandoned |
Array
(
[id] => 13490177
[patent_doc_number] => 20180296631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => HYDROGEL COMPOSITION AND ASSOCIATED METHOD OF USE
[patent_app_type] => utility
[patent_app_number] => 15/952004
[patent_app_country] => US
[patent_app_date] => 2018-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18953
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15952004
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/952004 | HYDROGEL COMPOSITION AND ASSOCIATED METHOD OF USE | Apr 11, 2018 | Abandoned |
Array
(
[id] => 15928161
[patent_doc_number] => 20200155714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => DUAL-TARGET IMAGING MOLECULAR PROBE, PREPARATION METHOD THEREFOR, AND APPLICATIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/605134
[patent_app_country] => US
[patent_app_date] => 2018-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3896
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16605134
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/605134 | DUAL-TARGET IMAGING MOLECULAR PROBE, PREPARATION METHOD THEREFOR, AND APPLICATIONS THEREOF | Apr 11, 2018 | Abandoned |
Array
(
[id] => 16090425
[patent_doc_number] => 20200199199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => MULTIBLOCK COPOLYPEPTIDES OF ELASTIN-BASED POLYPEPTIDES AND MUSSEL FOOT PROTEINS WITH STIMULI-RESPONSIVENESS AND SURFACE-ADHESIVE, METHODS OF PREPARING THEREOF AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/500177
[patent_app_country] => US
[patent_app_date] => 2018-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12797
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16500177
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/500177 | Multiblock copolypeptides of elastin-based polypeptides and mussel foot proteins with stimuli-responsiveness and surface-adhesive, methods of preparing thereof and use thereof | Apr 4, 2018 | Issued |
Array
(
[id] => 14055469
[patent_doc_number] => 10232011
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-19
[patent_title] => Formulations of guanylate cyclase C agonists and methods of use
[patent_app_type] => utility
[patent_app_number] => 15/924940
[patent_app_country] => US
[patent_app_date] => 2018-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 39171
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15924940
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/924940 | Formulations of guanylate cyclase C agonists and methods of use | Mar 18, 2018 | Issued |
Array
(
[id] => 20130222
[patent_doc_number] => 12372529
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-29
[patent_title] => Use of CD36 to identify cancer subjects for treatment
[patent_app_type] => utility
[patent_app_number] => 15/922349
[patent_app_country] => US
[patent_app_date] => 2018-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 6751
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15922349
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/922349 | Use of CD36 to identify cancer subjects for treatment | Mar 14, 2018 | Issued |
Array
(
[id] => 14099225
[patent_doc_number] => 20190091288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => TOPICAL PHARMACEUTICAL OR COSMETIC COMPOSITIONS AS WELL AS MEDICAL DEVICES COMPRISING THEREOF FOR THE TREATMENT OF SKIN DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/097176
[patent_app_country] => US
[patent_app_date] => 2018-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13120
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16097176
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/097176 | TOPICAL PHARMACEUTICAL OR COSMETIC COMPOSITIONS AS WELL AS MEDICAL DEVICES COMPRISING THEREOF FOR THE TREATMENT OF SKIN DISORDERS | Mar 13, 2018 | Abandoned |